clarithromycin has been researched along with Preterm Birth in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arenas-Hernandez, M; Demery-Poulos, C; Farias-Jofre, M; Galaz, J; Gomez-Lopez, N; Kawahara, N; Liu, TN; Liu, Z; Motomura, K; Padron, J; Panaitescu, B; Romero, R | 1 |
Ha Kim, Y; Jin, WH; Kim, A; Kim, JW; Kim, TY; Yang, Y | 1 |
2 other study(ies) available for clarithromycin and Preterm Birth
Article | Year |
---|---|
Clarithromycin prevents preterm birth and neonatal mortality by dampening alarmin-induced maternal-fetal inflammation in mice.
Topics: Alarmins; Amniotic Fluid; Animals; Chorioamnionitis; Clarithromycin; Female; HMGB1 Protein; Humans; Infant; Infant Mortality; Infant, Newborn; Inflammation; Mice; Pregnancy; Premature Birth | 2022 |
Antibiotic treatment of amniotic fluid "sludge" in patients during the second or third trimester with uterine contraction.
Topics: Adult; Amniotic Fluid; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Cohort Studies; Female; Humans; Metronidazole; Obstetric Labor, Premature; Pregnancy; Pregnancy Trimester, Third; Premature Birth; Retrospective Studies; Uterine Contraction | 2021 |